Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine mixed with fospropofol disodium for reducing paresthesia during general anesthesia induction
ChiCTR2300071330Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- May 2023
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of lidocaine and fospropofol disodium in paresthesia (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Rate of paresthesia. Planned start May 2023; status: not yet recruiting.
02
Drugs
lidocainefospropofol disodium
03
Conditions
paresthesia
Beyond the preview
Go deeper on ChiCTR2300071330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071330.